| Literature DB >> 35800135 |
Camila Felix Vecchi1, Rafaela Said Dos Santos1, Jéssica Bassi da Silva1, Marcos Luciano Bruschi1.
Abstract
Microneedles (MNs) are a means to break the protective skin barrier in a minimally invasive way. By creating temporary micropores, they make biologically active agents available in the skin layers. Propolis (PRP) is a gum resin with a complex chemical composition, produced by bees Apis mellifera L. and showing several therapeutic properties (i.e., antibacterial, antiviral, antifungal, anti-inflammatory, healing, and immunomodulatory properties). The administration of PRP extracts by conventional routes has some disadvantages, such as running off over the skin in liquid or emulsion form. When taken orally, the extracts have a strong and unpleasant taste. The aim of this work was to fabricate and characterize microneedles containing polyvinyl alcohol, polyvinylpyrrolidone, poloxamer P407, and an ethanolic or glycolic extract of PRP. Also, the obtained structures were microscopically and mechanically characterized. The results of the mechanical analysis showed that formulations containing 3% of P407 presented the highest compression values in a hard surface, which was also confirmed by the height and base values of the morphological analysis and by the microscopy images. It was possible to design MNs and select the best formulations for future tests. MNs containing an ethanolic extract of PRP showed to be better structured than MNs containing a glycolic extract of PRP. The MNs obtained in these studies proved to be a promising platform for the topical application of PRP.Entities:
Keywords: development; mechanical; microneedles; propolis extract; technology
Year: 2022 PMID: 35800135 PMCID: PMC9194495 DOI: 10.3762/bjnano.13.42
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.272
Figure 1Micrographs obtained by optical microscopy showing the structure of the microneedles containing ethanolic extract of propolis (E1 to E9); magnification 40×.
Figure 2Micrographs obtained by optical microscopy showing the structure of microneedles containing glycolic extract of propolis (G1 to G9); magnification 40×. Arrows represent locations where bubbles are present.
Figure 3Micrographs obtained by scanning electron microscopy (SEM) showing the surface morphology microneedles containing ethanolic extract of propolis (E1 to E9); magnification 150×.
Figure 4Micrograph obtained by scanning electron microscopy (SEM) showing the surface morphology of microneedles containing glycolic extract of propolis (G1 to G9); magnification 150×.
Figure 7Schematic representation for the analysis of the height and base measurements of the microneedles.
Size analysis of microneedles containing ethanolic (EE) or glycolic extract (GE) of propolis.
| EE | GE | ||||
|
|
|||||
| Formulation | Height (mm) | Base (mm) | Formulation | Height (mm) | Base (mm) |
|
|
|||||
| E1 | 1.6896 ± 0.0835 | 0.3471 ± 0.0029 | G1 | 1.8310 ± 0.0305 | 0.3046 ± 0.0036 |
| E2 | 1.8220 ± 0.0398 | 0.3109 ± 0.0080 | G2 | 1.4469 ± 0.4359 | 0.3290 ± 0.0088 |
| E3 | 1.6402 ± 0.0074 | 0.3262 ± 0.0018 | G3 | 1.3802 ± 0.2444 | 0.2978 ± 0.0094 |
| E4 | 1.6483 ± 0.0167 | 0.3216 ± 0.0151 | G4 | 1.5806 ± 0.0173 | 0.2786 ± 0.0049 |
| E5 | 1.7946 ± 0.0193 | 0.3125 ± 0.0079 | G5 | 1.4446 ± 0.2019 | 0.3097 ± 0.0191 |
| E6 | 1.9248 ± 0.0269 | 0.3174 ± 0.0119 | G6 | 1.4007 ± 0.3192 | 0.2671 ± 0.0150 |
| E7 | 1.9182 ± 0.0362 | 0.3419 ± 0.0134 | G7 | 1.6577 ± 0.2206 | 0.3357 ± 0.0193 |
| E8 | 1.8138 ± 0.0110 | 0.3279 ± 0.0117 | G8 | 1.6384 ± 0.0454 | 0.3304 ± 0.0096 |
| E9 | 1.7891 ± 0.0249 | 0.3418 ± 0.0022 | G9 | 1.6279 ± 0.1809 | 0.2910 ± 0.0115 |
Figure 5Response surface plots for height and base measurements of MNs containing EE or GE. The color scale is indicated in each figure and shows the isoparametric values.
Equations obtained for the height and base responses with the correlation coefficient r.
| EE | GE | |||
|
|
||||
| Equation |
|
Equation |
|
|
|
|
||||
| Height | 0.9167 | 0.3583 | ||
| Base | 0.7218 | 0.8316 | ||
Compression force and compression area of MNs containing EE or GE on a hard glass surface. Each analysis was performed, at least, in triplicate.
| Formulation | Compression force (N) | Compression area (N·mm) | Formulation | Compression force (N) | Compression area (N·mm) |
|
|
|||||
| E1 | 0.6133 ± 0.0984 | 7.9167 ± 1.2208 | G1 | 0.3075 ± 0.0170 | 2.5867 ± 0.2097 |
| E2 | 0.6034 ± 0.0489 | 10.9777 ± 4.0329 | G2 | 0.2220 ± 0.0233 | 2.4287 ± 0.5104 |
| E3 | 0.6475 ± 0.0493 | 7.6293 ± 1.5393 | G3 | 0.4153 ± 0.1330 | 4.9460 ± 1.9119 |
| E4 | 0.3436 ± 0.0383 | 2.4487 ± 0.5678 | G4 | 0.3090 ± 0.0001 | 2.2160 ± 0.0001 |
| E5 | 0.3392 ± 0.2011 | 2.4637 ± 1.5757 | G5 | 0.6140 ± 0.1005 | 7.1507 ± 1.7283 |
| E6 | 0.5229 ± 0.0346 | 4.6517 ± 1.1466 | G6 | 0.4833 ± 0.0298 | 4.5703 ± 0.6339 |
| E7 | 1.1130 ± 0.2569 | 19.0077 ± 4.9568 | G7 | 0.2260 ± 0.0001 | 2.0580 ± 0.0001 |
| E8 | 1.1981 ± 0.0231 | 18.5693 ± 3.2540 | G8 | 0.1245 ± 0.0001 | 1.1800 ± 0.0001 |
| E9 | 1.2345 ± 0.0138 | 15.9167 ± 0.4926 | G9 | 0.2053 ± 0.0124 | 1.4380 ± 0.1895 |
Figure 6Response surface plots for force and compression area of MNs containing EE or GE. The color scale is indicated in each figure and shows the isoparametric values.
Compression force (N) of the selected MN formulations applied on different surfaces (PVC film, Parafilm M, gelatin and porcine skin). Each analysis was performed, at least, in triplicate.
| Formulations | Force (N) | |||
|
|
||||
| PVC film | Parafilm M | Gelatin | Porcine skin | |
|
|
||||
| E3 | 0.4247 ± 0.0123 | 0.3863 ± 0.0090 | 0.1479 ± 0.0129 | 0.0979 ± 0.0017 |
| E6 | 0.5085 ± 0.0116 | 0.6319 ± 0.0253 | 0.2726 ± 0.0094 | 0.1431 ± 0.0093 |
| E9 | 0.5492 ± 0.0161 | 0.7476± 0.0394 | 0.2737 ± 0.0120 | 0.1438 ± 0.0055 |
| G6 | 0.3989 ± 0.0031 | 0.3422 ± 0.0164 | 0.2231 ± 0.0103 | 0.0866 ± 0.0064 |
| MNs without propolis extract | 0.1369 ± 0.0099 | 0.3429 ± 0.0857 | 0.1030 ± 0.0041 | 0.1893 ± 0.0158 |
| Stainless still MNs (standard model) | 0.1543 ± 0.0109 | 0.7943 ± 0.0525 | 0.3589 ± 0.0108 | 0.2406 ± 0.0231 |
Experimental 32 design utilized for the development of microneedles (MNs) composed of polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) in a fixed 1:1 ratio, poloxamer 407 (P407), and ethanolic propolis extract (EE) or glycolic propolis extract (GE).
| Independent variables | Levels | ||
|
|
|||
| Low (−1) | Central (0) | High (+1) | |
|
|
|||
| 1 | 2 | 3 | |
| 4 | 8 | 12 | |
| 2 | 4 | 8 | |
|
|
|||
| Standard run (formulations) |
|
|
|
|
|
|||
| E1 | −1 | −1 | |
| E2 | 0 | −1 | |
| E3 | +1 | 0 | |
| E4 | −1 | 0 | |
| E5 | 0 | +1 | |
| E6 | +1 | +1 | |
| E7 | −1 | −1 | |
| E8 | 0 | −1 | |
| E9 | +1 | 0 | |
| G1 | −1 | 0 | |
| G2 | 0 | +1 | |
| G3 | +1 | +1 | |
| G4 | −1 | −1 | |
| G5 | 0 | −1 | |
| G6 | +1 | 0 | |
| G7 | −1 | 0 | |
| G8 | 0 | +1 | |
| G9 | +1 | +1 | |
aformulations containing EE (block a); bformulations containing E (block b).